Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome.

To estimate whether progestin-induced endometrial shedding, before ovulation induction with clomiphene citrate, metformin, or a combination of both, affects ovulation, conception, and live birth rates in women with polycystic ovary syndrome (PCOS).
A secondary analysis of the data from 626 women with PCOS from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network trial was performed. Women had been randomized to up to six cycles of clomiphene citrate alone, metformin alone, or clomiphene citrate plus metformin. Women were assessed for occurrence of ovulation, conception, and live birth in relation to prior bleeding episodes (after either ovulation or exogenous progestin-induced withdrawal bleed).
Although ovulation rates were higher in cycles preceded by spontaneous endometrial shedding than after anovulatory cycles (with or without prior progestin withdrawal), both conception and live birth rates were significantly higher after anovulatory cycles without progestin-induced withdrawal bleeding (live births per cycle: spontaneous menses 2.2%; anovulatory with progestin withdrawal 1.6%; anovulatory without progestin withdrawal 5.3%; P<.001). The difference was more marked when rate was calculated per ovulation (live births per ovulation: spontaneous menses 3.0%; anovulatory with progestin withdrawal 5.4%; anovulatory without progestin withdrawal 19.7%; P<.001).
Conception and live birth rates are lower in women with PCOS after a spontaneous menses or progestin-induced withdrawal bleeding as compared with anovulatory cycles without progestin withdrawal. The common clinical practice of inducing endometrial shedding with progestin before ovarian stimulation may have an adverse effect on rates of conception and live birth in anovulatory women with PCOS.
AuthorsMichael P Diamond, Michael Kruger, Nanette Santoro, Heping Zhang, Peter Casson, William Schlaff, Christos Coutifaris, Robert Brzyski, Gregory Christman, Bruce R Carr, Peter G McGovern, Nicholas A Cataldo, Michael P Steinkampf, Gabriella G Gosman, John E Nestler, Sandra Carson, Evan E Myers, Esther Eisenberg, Richard S Legro,
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 119 Issue 5 Pg. 902-8 (May 2012) ISSN: 1873-233X [Electronic] United States
PMID22525900 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
Chemical References
  • Drug Combinations
  • Fertility Agents, Female
  • Menstruation-Inducing Agents
  • Progestins
  • Clomiphene
  • Metformin
  • Adult
  • Clomiphene (administration & dosage)
  • Double-Blind Method
  • Drug Administration Schedule
  • Drug Combinations
  • Female
  • Fertility Agents, Female (administration & dosage)
  • Fertilization
  • Humans
  • Live Birth
  • Menstruation (drug effects)
  • Menstruation-Inducing Agents (administration & dosage, pharmacology)
  • Metformin (administration & dosage)
  • Ovulation
  • Ovulation Induction (methods)
  • Polycystic Ovary Syndrome
  • Pregnancy
  • Pregnancy Complications
  • Progestins (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: